Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
about
Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled studyCharacterizing sexual function in patients with generalized anxiety disorder: a pooled analysis of three vilazodone studies.Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.Antidepressants and sexual dysfunction: mechanisms and clinical implications.Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Why do some promising brain-stimulation devices fail the next steps of clinical development?Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trialA review of vilazodone, serotonin, and major depressive disorder.Continuation treatment of major depressive disorder: is there a case for duloxetine?Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.Serotonin reuptake inhibitor citalopram inhibits GnRH synthesis and spermatogenesis in the male zebrafish.Sexual side-effects of contemporary antidepressants: review.Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.Sexuality after breast cancer: need for guideline.Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.Factors influencing fluoxetine-induced sexual dysfunction in female rats.Testosterone therapy for reduced libido in womenUse of an operant paradigm for the study of antidepressant-induced sexual dysfunctionWomen's sexual function and dysfunction: current uncertainties, future directions.The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder.Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trialUse of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.Sexual function of women with chronic illness and cancer.A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.Assessment and management of sexual dysfunction in the context of depression.
P2860
Q28254377-BF66252B-BE77-4F8C-B2FE-522FACE28441Q30276416-30351A05-A399-406D-8AB6-191F25357217Q30278078-E62FCC21-57B6-41B3-AFFC-9EB70742053CQ30384691-C05F1EFE-FAC0-40B8-9689-6042AAEE48F9Q30457019-BF3C506B-EAF0-4ED3-A203-4F283201C23DQ30457744-ECF0916A-7A68-43B8-93CB-48916BB91949Q30458935-6196AEA3-B281-47B6-A9A2-A40E18E2D629Q33519672-373D6503-1B6E-4513-9EB5-90A98C476634Q33690148-0385A2EE-9816-45E3-9A3A-9C2C9C0C84F2Q33721197-6945E4D1-31E6-4DA0-8C77-4BFC4D4F82EAQ33755767-E734B39D-0631-41AA-B3CF-A5C6AA04A3A3Q34072466-8D61F63C-F6BF-435C-A6A3-609B52B720B8Q34084735-21BE9167-383D-4DC9-9327-178C5A65ADECQ34236311-A31EE922-A15A-4CB4-A4F3-EE1177237723Q34671415-2339AD7F-7077-410B-81DA-3BAA27BE701CQ34996668-C72AE14F-E37C-4319-971C-BFABBBFDF39BQ35066804-D3B8E595-3AB0-4414-9C69-B6CA9993FFCEQ35156189-566600C7-B048-4941-AAF0-F08DF10CCECEQ35755912-BE278A3C-A3BF-4F86-B0CE-38E0F62EE33BQ36204980-0F355EC9-17AE-4716-9104-C0D4F80B353AQ36327962-D8106083-1F5F-427D-87D9-232ABD61127EQ36355624-4299B8F9-9EBD-48CC-98FB-A207BEF8F1A9Q37189297-823CDC75-CB30-447C-887A-12F160C0C383Q37299972-560EF0A3-04BB-45DC-9151-41CDFB9F111AQ37363551-53C181B2-CBE7-42FF-B8CB-12CA6BBD2DFBQ37733559-87C69FCC-AB4C-4A4A-9B44-4CD945431785Q37738879-17D78BDF-CB41-49FB-B0B1-2727A4034913Q38020236-12B3B37A-EF17-43EC-8528-4BB578F794C5Q47623703-6B714B92-E1AC-4F6F-97B6-74B903B51A7CQ47653061-356E1122-8050-46F8-B24A-B426880E6C6C
P2860
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Changes in sexual functioning ...... ith major depressive disorder.
@ast
Changes in sexual functioning ...... ith major depressive disorder.
@en
type
label
Changes in sexual functioning ...... ith major depressive disorder.
@ast
Changes in sexual functioning ...... ith major depressive disorder.
@en
prefLabel
Changes in sexual functioning ...... ith major depressive disorder.
@ast
Changes in sexual functioning ...... ith major depressive disorder.
@en
P2093
P1476
Changes in sexual functioning ...... ith major depressive disorder.
@en
P2093
Apurva Prakash
Craig Mallinckrodt
Madelaine Wohlreich
Susan Kornstein
P304
P356
10.1111/J.1743-6109.2007.00520.X
P433
P577
2007-07-01T00:00:00Z